Clinical Trial Update: Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients [Phase 2]

View source ↗

Summary

A Phase 2 pharmacokinetics/pharmacodynamics biomarker study in active ulcerative colitis was completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Snippet

Sponsor: Pfizer | Conditions: Colitis, Ulcerative | Phase 2 | Status: COMPLETED | Results posted: 2014-11-18